Bringing the fundamentals into focus…
Back to Arrowhead Pharmaceuticals, Inc.
How Arrowhead Pharmaceuticals, Inc. stacks up
ARWR · against 163 other Healthcare companies of similar size
Growth
74/ 100
Above the middle of the pack.
Ranked #59 of 164 · scores higher than 63% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 70–79, including ARWR · Click a bar to see the companies
Why growth scores 74?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 74% of peers. Revenue growth: 16.8% vs peer median 6.1%
- faster revenue growth over three years: stronger than 90% of peers. 3-year revenue growth: 37.7% vs peer median 5.8%
Metric by metric
Position: dot = ARWR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARWR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 164 reported | 16.8% | 10.2% | 67% | 33% | |
| Earnings per share growthHigher is better · 118 reported | Not reported | 12.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 158 reported | 37.7% | 10.7% | 88% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ARWR| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 7.3B USD | 97 | 74 | |
| 54 | 871.6B INR (≈$10.5B) | 76 | 66 | |
| 56 | 679.6B INR (≈$8.2B) | 75 | 77 | |
| 56 | 4.7B USD | 75 | 46 | |
| 56 | 13.9B EUR (≈$15.3B) | 75 | 78 | |
| 59 | 8.4B USD | 74 | 28 | |
| 59 | 11.4B USD | 74 | 64 | |
| 59 | 5.3B USD | 74 | 63 | |
| 62 | 1.21T JPY (≈$8.2B) | 72 | 74 | |
| 63 | 8.4B USD | 71 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score